The Food and Drug Administration (FDA) is updating the public on the status of influenza vaccine availability for the 2005-2006 influenza season. The FDA anticipates the production of more vaccine than last year. At this time, the agency says it does not know the exact number of doses to be distributed, but despite Chiron's lowered projections announced today, it still anticipates that there will be significantly more vaccine produced than last year.
"A tremendous amount of work by FDA, MHRA, and the firm has brought us to the point that will allow Chiron to distribute influenza vaccine for this flu season," said Dr. Jesse Goodman, director of the FDA's Center for Biologics Evaluation and Research. "However, as with all influenza vaccine manufacturers, Chiron's influenza vaccine must undergo safety testing and lot release evaluation before it can be released to the market."
The FDA is committed to working with all of the influenza vaccine manufacturers to expedite product lot release and availability of vaccine. While occasional spot shortages may occur as manufacturers complete their final testing, the agency says it expects these shortages to resolve as vaccine continues to be released to healthcare providers and others who administer the vaccine.
There are four manufacturers distributing influenza vaccine this year: Sanofi Pasteur, Inc., MedImmune Vaccines, Inc., GlaxoSmithKline Biologicals, and Chiron. The FDA has been actively working with them to ensure an adequate, safe, and effective supply of vaccine. As part of this overall effort, the agency has had close interactions with the Medicines and Healthcare Products Regulatory Agency (MHRA, the U.K. regulatory authority) and Chiron, as the company has worked to correct the problems that led to its license suspension by MHRA.
Influenza season may begin as early as October and run through May. The best time to get vaccinated is in October or November, but getting vaccinating in December or later still can be beneficial.
Source: FDA
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.
Beyond the Surface: Rethinking Environmental Hygiene Validation at Exchange25
June 30th 2025Environmental hygiene is about more than just shiny surfaces. At Exchange25, infection prevention experts urged the field to look deeper, rethink blame, and validate cleaning efforts across the entire care environment, not just EVS tasks.
A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides
June 26th 2025As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.